These include inducing apoptosis specifically in cancer cells via CB2R activation, inhibiting cell proliferation through pathways like PI3 K/AKT and MAPK, reducing angiogenesis to limit tumor growth, modulating the tumor microenvironment to enhance immune detection, and lowering inflammation associated with cancer progression. The gene discussed is AKT1; the disease is cancer.